Concepedia

Admission Heart Rate Predicts Mortality Following Primary Percutaneous Coronary Intervention for <scp>ST</scp>‐Elevation Myocardial Infarction: An Observational Study

Awsan Noman, Karthik Balasubramaniam, Rajiv Das, D. S. C. Ang, Vijay Kunadian, Taida Ivanauskienė, Azfar Zaman

Cardiovascular Therapeutics · 2013 · 20 citations · 21 references

DOI

Abstract

Elevated admission heart rate in PPCI-treated STEMI patients is associated with long-term all-cause mortality. Beta blocker therapy improved postdischarge survival in patients with elevated admission heart rate.

References

21

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Karl Swedberg, Michel Komajda, Michael Böhm et al. · The Lancet · 2010 · 2.5K citations · Full text

, , +7

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation

European Heart Journal · 2008 · 2.3K citations · Full text

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)

Frederick G. Kushner, Mary M. Hand, Sidney C. Smith et al. · Circulation · 2009 · 1.7K citations · Full text

, , +11

A Validated Prediction Model for All Forms of Acute Coronary Syndrome

Kim A. Eagle, Michael J. Lim, Omar Dabbous et al. · JAMA · 2004 · 1.6K citations

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Kim Fox, Ian Ford, Philippe Gabríel Steg et al. · The Lancet · 2008 · 1.1K citations · Full text

, , +9